HEALING AGENT IS A GROWING PROJECT

Written on the 9 August 2012 by James Perkins

HEALING AGENT IS A GROWING PROJECT

AN INVESTMENT in medical science seven years ago is about to reap worldwide rewards for a Brisbane company.

A breakthrough tissue-healing treatment developed by a Brisbane scientist is on the brink of being launched into international medical markets.

It was a chance meeting at a Boston biotechnology conference seven years ago that first put the project on the path to commercialisation.

Professor Zee Upton (pictured) and financier Greg Baynton worked in Brisbane offices just two kilometres apart.

But they had never met until they happened to share a table during a dinner break at the Boston conference.

Upton, a Queensland University of Technology biotechnology professor, was in the early stages of developing VitroGro ECM and enthusiastically described to Baynton how her product assisted in treating complex and difficult-to-heal wounds.

In lay terms, VitroGro ECM produces a favourable environment for healing. It acts like an adhesive agent, holding new cells in place while they begin the skin repair process.

Baynton, founder and managing director of Orbit Capital, was intrigued. Shortly after his initial meeting with Upton, he agreed to sink funds into the project.

After many stages of development and research, VitroGro ECM is on course to be launched in Europe this year by Brisbanebased Tissue Therapies.

Baynton is a director of the company. In a boost for the product’s worldwide profile, Tissue Therapies has been asked to showcase the product as the same Boston conference where Baynton and Upton first met.

Tissue Therapies CEO Steve Mercer says it is an “honour’’ to present a session at 2012 BIO, which will be attended by about 15,000 delegates from more than 60 countries.

“It is quite rare that a small company will be given the opportunity to present a session, and even rarer for a company from outside the United States to do so and we are grateful for the opportunity,” he says.

There are four patents pending on VitroGro ECM. It has succeeded in pre-clinical and clinical trials and the company has an application for sale lodged with the European Union.

“Following the EU application, we will lodge applications for sale in both Australia and Canada, as they have mutual agreements with the markets in the EU,” says Mercer.

There are 12 pallets of VitroGro ECM ready to go once the European authorities give it the all clear.

A further clinical trial of the product for the treatment of chronic venous ulcers will be done in the United States later this year.


Author: James Perkins Connect via: Twitter LinkedIn

Latest News

WHY VIDEO IS A "GIVEN" FOR BUSINESS

IN TODAY's digital-driven world, video is king and if used right, it can push a company's brand and brand ...

BRAMBLES TUMBLES AFTER REDUCING GUIDANCE

BRAMBLES (ASX: BXB) will miss its first-half guidance due to cost pressures at its North America business.

The com...

VILLAGE ROADSHOW PARKS HURT BY DREAMWORLD TRAGEDY

QUEENSLAND visitors to Village Roadshow (ASX: VRL) theme parks have declined 12 per cent in the wake of four deaths a...

ASF UNVEILS TRAFFIC PLANS FOR THE SPIT

A SECOND bridge over the Nerang River is the centrepiece of the ASF Consortium's plan to improve traffic flow ...

Related News

CARSALES CEO RETIRES AS NEW COMPETITOR COX FINALISES MERGER

CARSALES will have a new CEO as it takes on a fresh challenger to its crown as the dominant online car sales portal i...

BUSINESS CONFIDENCE AT A SIX-YEAR HIGH

SMALL and medium businesses have entered 2017 with their confidence at a six-year high, building on strong gains m...

CONSUMERS PESSIMISTIC ENTERING 2017

CONSUMER confidence remains at its weakest point since April 2016, according to the latest Westpac Melbourne Institut...

RISE OF STARTUP SUPPORT PROGRAMS NOT AS ROSY AT IT SEEMS

ENTREPRENEURIAL cultivation companies in Australia are appearing quickly, but questions have been raised about whe...

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter